| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_101b79f46b9c36f4854cd212b4880442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_816ba8e2b5fab8d848c954c1de602af2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3a35255c32c75b68019135fb52a33e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e909047e08224404c3849eb4a8b07f03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d1bd0c506e4c424d84fe30c5ba87e73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dff91ea4e59f45452ebec068aa4be559 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-015 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-20 |
| filingDate |
2011-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5166632f2cf8bc6114b826484fa7e493
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee849c4705c286ccd6dae4b083afdd30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d81daece2279956d1b72fa268a3b36d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2aefba44cd2cb432a5092df74b13f0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3029afa71260d4ba6127740436edb7c |
| publicationDate |
2012-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012046081-A1 |
| titleOfInvention |
Malaria vaccine |
| abstract |
Immunogenic compositions and vaccines against Plasmodialinfection comprising an Rh polypeptide or a fragment or variant thereof are dislcosed. Also disclosed are Rh5 polypeptides or fragments or variants thereof capable of binding CD147 and conferring protection against infection and/or disease caused by multiple Plasmodial strains or Plasmodialspecies, inhibitors of the interaction between Rh5 and CD147 and methods for producing polypeptides in a mammalian expression system. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020074908-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012114125-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11096999-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11273212-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017209558-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018088507-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018088509-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016016651-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110168086-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9181313-B2 |
| priorityDate |
2010-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |